[Clinical administration of lithiumaspartate].
D000085:Acetates / Q000097:blood / Q000652:urine; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001224:Aspartic Acid / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D001702:Biopharmaceutics; D001714:Bipolar Disorder / Q000188:drug therapy; D002254:Carbonates / Q000097:blood / Q000652:urine; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D003863:Depression / Q000188:drug therapy; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D013431:Sulfates / Q000097:blood / Q000652:urine; D013997:Time Factors
D000085:Acetates; D002254:Carbonates; D003692:Delayed-Action Preparations; D013431:Sulfates; D001224:Aspartic Acid; D008094:Lithium
Zur klinischen Anwendung von Lithiumaspartat